← Open Payments lookup

BARBARA REED: Open Payments

NPI 1083864268 · SOUTHLAKE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,742 in 80 payments from 14 companies in 2025. Trend: 2023 $1,819 · 2024 $1,846 · 2025 $2,742

Food & beverage: $2,742
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$548
Axsome Therapeutics, Inc.9$476
Otsuka America Pharmaceutical, Inc.14$320
E.R. Squibb & Sons, L.L.C.10$230
Teva Pharmaceuticals USA, Inc.5$204
Supernus Pharmaceuticals, Inc.4$180
Alkermes, Inc.4$165
Takeda Pharmaceuticals U.S.A., Inc.12$152
Neurocrine BioSciences, Inc.5$122
Vanda Pharmaceuticals Inc.1$117

Products named: CAPLYTA, Auvelity, REXULTI, COBENFY, Qelbree, TRINTELLIX, AUSTEDO XR, LYBALVI.

Industry payments across TX — which companies pay providers there.